Literature DB >> 5250069

Uptake and phosphorylation of cytosine arabinoside by normal and leukemic human blood cells in vitro.

D Kessel, T C Hall, D Rosenthal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 5250069

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  23 in total

1.  Targeting SAMHD1 with the Vpx protein to improve cytarabine therapy for hematological malignancies.

Authors:  Nikolas Herold; Sean G Rudd; Linda Ljungblad; Kumar Sanjiv; Ida Hed Myrberg; Cynthia B J Paulin; Yaser Heshmati; Anna Hagenkort; Juliane Kutzner; Brent D G Page; José M Calderón-Montaño; Olga Loseva; Ann-Sofie Jemth; Lorenzo Bulli; Hanna Axelsson; Bianca Tesi; Nicholas C K Valerie; Andreas Höglund; Julia Bladh; Elisée Wiita; Mikael Sundin; Michael Uhlin; Georgios Rassidakis; Mats Heyman; Katja Pokrovskaja Tamm; Ulrika Warpman-Berglund; Julian Walfridsson; Sören Lehmann; Dan Grandér; Thomas Lundbäck; Per Kogner; Jan-Inge Henter; Thomas Helleday; Torsten Schaller
Journal:  Nat Med       Date:  2017-01-09       Impact factor: 53.440

2.  [Autoradiographic and enzyme-chemical studies of the DNA synthesis in leukemia cells. II. Thymidine-kinase and 3H-thymidine labelling index under cytostatic therapy].

Authors:  W Wilmanns; J Hartje
Journal:  Klin Wochenschr       Date:  1970-07-01

3.  The immunosuppressive activity of adamantoyl cytarabine. 3. Immunosuppressive specificity in rats.

Authors:  G D Gray; M M Mickelson
Journal:  Immunology       Date:  1970-09       Impact factor: 7.397

4.  The relationship of Ara-C metabolism in vitro to therapeutic response in acute myeloid leukaemia.

Authors:  A L Harris; D G Grahame-Smith
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

Review 5.  Antineoplastic drugs: clinical pharmacology and therapeutic use.

Authors:  R A Bender; L A Zwelling; J H Doroshow; G Y Locker; K R Hande; D S Murinson; M Cohen; C E Myers; B A Chabner
Journal:  Drugs       Date:  1978-07       Impact factor: 9.546

6.  Pharmacokinetics of cytosine arabinoside in patients with acute myeloid leukaemia.

Authors:  A L Harris; C Potter; C Bunch; J Boutagy; D J Harvey; D G Grahame-Smith
Journal:  Br J Clin Pharmacol       Date:  1979-09       Impact factor: 4.335

7.  Resistance to cytarabine induces the up-regulation of NKG2D ligands and enhances natural killer cell lysis of leukemic cells.

Authors:  Henry Ogbomo; Martin Michaelis; Denise Klassert; Hans Wilhelm Doerr; Jindrich Cinatl
Journal:  Neoplasia       Date:  2008-12       Impact factor: 5.715

8.  Nucleoside transport in mammalian cell membranes. III. Kinetic and chemical modification studies of cytosine-arabinoside and uridine transport in hamster cells in culture.

Authors:  O Heichal; O Bibi; J Katz; Z I Cabantchik
Journal:  J Membr Biol       Date:  1978-03-10       Impact factor: 1.843

9.  Abrogation of the prognostic significance of low leukemic cell retention of cytosine arabinoside triphosphate by intensification of therapy and by alteration in the dose and schedule of administration of cytosine arabinoside.

Authors:  H D Preisler; Y M Rustum; N Azarnia; R Priore
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

10.  Arabinofuranosyl nucleosides induce common fragile sites.

Authors:  J C Leonard; R C Leonard; K H Thompson
Journal:  Hum Genet       Date:  1988-06       Impact factor: 4.132
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.